F Oberling
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Virus-based gene therapy research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 24
- Cancer Treatment and Pharmacology 6
- Neutropenia and Cancer Infections 6
-
- Lymphoma Diagnosis and Treatment 13
- Co-authors
- J L Binet (2 shared papers)C Jacquillat (1 shared paper)H Piguet (1 shared paper)Pierre Boivin (1 shared paper)M. Thomas (1 shared paper)Claude Chastang (1 shared paper)Claude Lesty (1 shared paper)G Vaugier (1 shared paper)
- Journals
- Cancer (5 papers)Cancer Immunology Immunotherapy (4 papers)Leukemia Research (3 papers)Annals of Oncology (3 papers)Annals of Hematology (3 papers)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
F Oberling
105 papers receiving 2.7k citations
F Oberling's Hit Papers
Peers
Comparison fields: 5 of 112
- Genetics 1.4k
- Pathology and Forensic Medicine 1.1k
- Immunology 973
- Hematology 394
- Oncology 522
Countries citing papers authored by F Oberling
This map shows the geographic impact of F Oberling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Oberling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Oberling more than expected).
Fields of papers citing papers by F Oberling
This network shows the impact of papers produced by F Oberling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Oberling. The network helps show where F Oberling may publish in the future.
Co-authors
The 25 scholars most cited alongside F Oberling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Hit paper breakdown → | 1981 | 1282 |
| 2 | An electron microscopy study into the mechanism of gene transfer with lipopolyamines. | 1996 | 245 |
| 3 | 1996 | 141 | |
| 4 | 1992 | 76 | |
| 5 | 1993 | 70 | |
| 6 | 1990 | 63 | |
| 7 | 1994 | 58 | |
| 8 | 1990 | 55 | |
| 9 | 1991 | 52 | |
| 10 | 1991 | 46 | |
| 11 | 1998 | 45 | |
| 12 | 1988 | 42 | |
| 13 | 1976 | 40 | |
| 14 | High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in France. | 1990 | 40 |
| 15 | 1988 | 35 | |
| 16 | E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. | 1996 | 31 |
| 17 | 1977 | 28 | |
| 18 | 1994 | 27 | |
| 19 | 1979 | 24 | |
| 20 | 1995 | 24 |
About F Oberling
F Oberling is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Hematology and Genetics, having authored 111 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (10 papers), Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (10 papers), Ovarian cancer diagnosis and treatment (7 papers), Cancer Treatment and Pharmacology (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Neutropenia and Cancer Infections (6 papers). The work is most often cited by research in Genetics (1.4k citations), Pathology and Forensic Medicine (1.1k citations), Immunology (973 citations), Hematology (394 citations) and Oncology (522 citations). F Oberling has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include J L Binet, C Jacquillat, H Piguet, Pierre Boivin, M. Thomas, Claude Chastang, Claude Lesty, G Vaugier, Ariane Auquier and F Grémy. Their work appears in journals such as Cancer, Cancer Immunology Immunotherapy, Leukemia Research, Annals of Oncology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.